tirzepatide semaglutide user reviews comparison vs. Tirzepatide: Which GLP-1 Is Right for You? Tirzepatide vs semaglutide and liraglutide

Pictured: Woman grasping her stomach in pain/iStock, Doucefleur The use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, such as Novo Nordisks Ozempic and Wegovy, is associated with the risk of gastrointestinal adverse events, according to a study published Thursday in the medical journal JAMA

Medicine and science in sports and exercise , 34 (2), 332343

Common side effects during the first 24 weeks include mild nausea, reduced appetite, and occasional constipation as your body adjusts

Persistent nausea can also signal dehydration, medication interactions, or underlying conditions unrelated to semaglutide

Prevalence of gastrointestinal symptoms in patients with type 2 diabetes: a population-based study

Swine Dosage: Inject subcutaneously or intramuscularly at the instructions of your veterinarian